![Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial - The Lancet Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial - The Lancet](https://www.thelancet.com/cms/asset/73ac20d2-0458-4c0f-91e3-fd1c10e05b5d/gr1.jpg)
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial - The Lancet
![Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial - The Lancet Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/2047891701/2058122535/gr1.gif)
Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial - The Lancet
![Ligand-binding domains of nuclear receptors facilitate tight control of split CRISPR activity | Nature Communications Ligand-binding domains of nuclear receptors facilitate tight control of split CRISPR activity | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fncomms12009/MediaObjects/41467_2016_Article_BFncomms12009_Fig1_HTML.jpg)
Ligand-binding domains of nuclear receptors facilitate tight control of split CRISPR activity | Nature Communications
![Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial - The Lancet Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/058e591a-d23b-4a9c-bed8-872bd2b0361a/gr1.gif)